A rizona S tudy of A ging and N eurodegenerative D isorders and B rain and B ody D onation P rogram

Cites (347)

Items 201–347 of 347

1. Multivalent Binding of Complement Protein C1q to the Amyloid β-Peptide (Aβ) Promotes the Nucleation Phase of Aβ Aggregation
   Webster, S., Glabe, C., Rogers, J. · 1995 · Biochemical and Biophysical Research Communications
2. C9ORF72 repeat expansions in cases with previously identified pathogenic mutations
   Marka van Blitterswijk, Matthew Baker, Mariely DeJesus‐Hernandez, Roberta Ghidoni, Luisa Benussi, Elizabeth C. Finger, Ging‐Yuek Robin Hsiung, Brendan J. Kelley, Melissa Erin Murray, Nicola J. Rutherford et al. · 2013 · Neurology
3. Amyloid load in nondemented brains correlates with APOE e4
   Richard J. Caselli, Douglas G. Walker, Lucia I. Sue, Marwan Noel Sabbagh, Thomas G. Beach · 2010 · Neuroscience Letters
4. [18F]Flutemetamol PET imaging and cortical biopsy histopathology for fibrillar amyloid β detection in living subjects with normal pressure hydrocephalus: pooled analysis of four studies
   Juha O. Rinne, Dean Foster Wong, David A. Wolk, Ville Leinonen, Steven Edward Arnold, Christopher J. Buckley, Adrian P L Smith, Richard W. McLain, Paul F. Sherwin, Gill Farrar et al. · 2012 · Acta Neuropathologica
5. A nation-wide study of atherosclerosis in infants, children and young adults in Japan
   Kentaro Tanaka, Junichi Masuda, Tsukasa Imamura, Katsuo Sueishi, Teruyuki Nakashima, Isamu Sakurai, Tsuyoshi Shozawa, Yasuhiro Hosoda, Yoji Yoshida, Yasuichi Nishiyama et al. · 1988 · Atherosclerosis
6. Alzheimer's Disease and Non-Demented High Pathology Control Nonagenarians: Comparing and Contrasting the Biochemistry of Cognitively Successful Aging
   Chera L. Maarouf, Ian D. Daugs, Tyler A. Kokjohn, Douglas G. Walker, Jesse M. Hunter, Jane Kruchowsky, Randy L Woltjer, Jeffrey Alan Kaye, Eduardo Miguel Castaño, Marwan Noel Sabbagh et al. · 2011 · PLoS ONE
7. Sorl1 as an Alzheimer’s Disease Predisposition Gene?
   Jennifer Webster, Amanda J. Myers, John V. Pearson, David W. Craig, Diane Hu‐Lince, K. Coon, V. Zismann, T. Beach, D. Leung, Leslie Bryden et al. · 2007 · Neurodegenerative Diseases
8. Clinicopathological Outcomes of Prospectively Followed Normal Elderly Brain Bank Volunteers
   Brittany N. Dugger, Joseph G. Hentz, Charles H. Adler, Marwan Noel Sabbagh, Holly A. Shill, Sandra A. Jacobson, John N. Caviness, Christine M. Belden, Erika D. Driver‐Dunckley, Kathryn J. Davis et al. · 2014 · Journal of Neuropathology & Experimental Neurology
9. Functional, Global and Cognitive Decline Correlates to Accumulation of Alzheimers Pathology in MCI and AD
   Sabbagh, M.N., Cooper, K., DeLange, J., Stoehr, J.D., Thind, K., Lahti, T., Reisberg, B., Sue, L., Vedders, L., Fleming, S.R. et al. · 2010 · Current Alzheimer Research
10. Neuronal gene expression in non-demented individuals with intermediate Alzheimer's Disease neuropathology
    Winnie S. Liang, Travis L. Dunckley, Thomas G. Beach, Andrew Grover, Diego Mastroeni, Keri M. Ramsey, Richard J. Caselli, Walter A. Kukull, Daniel W. McKeel, John C. Morris et al. · 2008 · Neurobiology of Aging
11. High-resolution Quantification of Specific mRNA Levels in Human Brain Autopsies and Biopsies
    Anja Castensson, Lina Emilsson, Paul Preece, and Elena Jazin · 2000 · Genome Research
12. Charge-based binding of complement component C1q to the Alzheimer amyloid beta-peptide.
    Sarah M. Webster, Barry S. Bonnell, Joseph Rogers · 1997 · Europe PMC (PubMed Central)
13. Prospective collection of tissue samples at autopsy in children with diffuse intrinsic pontine glioma
    Alberto Broniscer, Justin Nathaniel Baker, Suzanne J. Baker, Susan N Chi, Jeffrey Russell Geyer, E. Brannon Morris, Amar J. Gajjar · 2010 · Cancer
14. Required techniques and useful molecular markers in the neuropathologic diagnosis of neurodegenerative diseases
    Dennis W. Dickson · 2005 · Acta Neuropathologica
15. Probable RBD is increased in Parkinson’s disease but not in essential tremor or restless legs syndrome
    Charles H. Adler, Joseph G. Hentz, Holly A. Shill, Marwan Noel Sabbagh, Erika D. Driver‐Dunckley, Virgilio Gerald H. Evidente, Sandra A. Jacobson, Thomas G. Beach, Bradley F. Boeve, John N. Caviness · 2011 · Parkinsonism & Related Disorders
16. Change in Body Mass Index Before and After Alzheimer’s Disease Onset
    Yian Gu, Nikolaos Scarmeas, Stephanie Cosentino, Jason Brandt, Marilyn Albert, Deborah Blacker, Bruno Dubois, Yaakov Stern · 2014 · Current Alzheimer Research
17. Striatal amyloid plaque density predicts braak neurofibrillary stage and clinicopathological Alzheimer's disease: Implications for amyloid imaging
    Beach, Thomas G., Sue, Lucia I., Walker, Douglas G., Sabbagh, Marwan N., Serrano, Geidy, Dugger, Brittany N., Mariner, Monica, Yantos, Kim, Henry-Watson, Jonette, Chiarolanza, Glenn et al. · 2012 · Journal of Alzheimer s Disease
18. TaqMan PCR assay in the control of RNA normalization in human post-mortem brain tissue
    Marta Barrachina, Esther Castaño, Isidró Ferrer · 2006 · Neurochemistry International
19. Effect of pre- and postmortem variables on specific mRNA levels in human brain
    W. J. Burke, Karen L. O’Malley, Hyung D. Chung, Steve Harmon, J. Philip Miller, Leonard H. van den Berg · 1991 · Molecular Brain Research
20. Recovery and Expression of Messenger RNA from Postmortem Human Brain Tissue
    Thomas J. Cummings, Jay C. Strum, Lawrence Wonsik Yoon, Mari H. Szymanski, Christine Marie Hulette · 2001 · Modern Pathology
21. Mitochondrial transcription factor A (Tfam) is a pro-inflammatory extracellular signaling molecule recognized by brain microglia.
    J. Little, Svetlana Simtchouk, Stephanie M. Schindler, Erika B. Villanueva, N. J. Gill, D. Walker, K. R. Wolthers, A. Klegeris · 2014 · Molecular and cellular neurosciences
22. Effect of RNA quality on transcript intensity levels in microarray analysis of human post-mortem brain tissues
    Tatiana G. Popova, Detlev Mennerich, Andreas Weith, Karsten Quast · 2008 · BMC Genomics
23. Characterisation of messenger RNA extracted post-mortem from the brains of schizophrenic, depressed and control subjects.
    C. W. Perrett, R. M. Marchbanks, S. A. Whatley · 1988 · Journal of Neurology Neurosurgery & Psychiatry
24. Stability of RNA transcripts in post-mortem psychiatric brains
    Maja Schramm, Peter Falkai, Ralf Tepest · 1999 · Journal of Neural Transmission
25. Substantia Nigra Marinesco Bodies Are Associated with Decreased Striatal Expression of Dopaminergic Markers
    Thomas G. Beach, Douglas G. Walker, Lucia I. Sue, Amanda Newell, Charles Adler, Jeffrey N. Joyce · 2004 · Journal of Neuropathology & Experimental Neurology
26. The isolation and in vitro translation of undegraded messenger RNAs from human postmortem brain
    Marcelle R. Morrison, W. Sue T. Griffin · 1981 · Analytical Biochemistry
27. Biochemical increase in phosphorylated alpha-synuclein precedes histopathology of Lewy-type synucleinopathies
    L. Lue, D. G. Walker, Charles Adler, Holly A. Shill, Hung Tran, H. Akiyama, L. Sue, J. Caviness, Marwan N. Sabbagh, Thomas G. Beach · 2012 · Brain Pathology
28. Loss of response to levodopa in Parkinson’s disease and co-occurrence with dementia: role of D3 and not D2 receptors
    Jeffrey N. Joyce, H. Ryoo, TG Beach, John N. Caviness, Mark A. Stacy, Eugenia V. Gurevich, Mark Reiser, Charles H. Adler · 2002 · Brain Research
29. Histopathological and molecular heterogeneity among individuals with dementia associated with Presenilin mutations
    Chera L. Maarouf, Ian D. Daugs, Salvatore Spina, Rubén Vidal, Tyler A. Kokjohn, Rebekah Patton, Walter M. Kalback, Dean C. Luehrs, Douglas G Walker, Eduardo Miguel Castaño et al. · 2008 · Molecular Neurodegeneration
30. Cerebrospinal fluid biomarkers of neuropathologically diagnosed Parkinson’s disease subjects
    Chera L. Maarouf, Thomas G. Beach, Charles H. Adler, Holly A. Shill, Marwan Noel Sabbagh, TERENCE L. WU, Douglas G Walker, Tyler A. Kokjohn, Alex E. Roher, Arizona PD Consortium · 2012 · Neurological Research
31. Assessing the Need for a Standardized Cancer HUman Biobank (caHUB): Findings From a National Survey With Cancer Researchers
    Holly A. Massett, N. L. Atkinson, D. Weber, R. Myles, C. Ryan, M. Grady, Carolyn C. Compton · 2011 · JNCI Monographs
32. Pituitary adenylate cyclase–activating polypeptide is reduced in Alzheimer disease
    Pengcheng Han, Winnie S. Liang, Leslie C. Baxter, Junxiang Yin, Zhiwei Tang, Thomas G. Beach, Richard J. Caselli, Eric M. Reiman, Jiong Shi · 2014 · Neurology
33. Human Tissue Ownership and Use in Research: What Laboratorians and Researchers Should Know
    Monica J. Allen, Michelle L. E. Powers, K Scott Gronowski, Ann M. Gronowski · 2010 · Clinical Chemistry
34. Postmortem Delay Has Minimal Effect on Brain RNA Integrity
    John F. Ervin, Erin L. Heinzen, Kenneth D. Cronin, David B. Goldstein, Mari H. Szymanski, James R. Burke, Kathleen Anne Welsh-Bohmer, Christine Marie Hulette · 2007 · Journal of Neuropathology & Experimental Neurology
35. On the Stability of Messenger RNA and Ribosomal RNA in the Brains of Control Human Subjects and Patients with Alzheimer's Disease
    Brian M. Ross, John T. Knowler, James McCulloch · 1992 · Journal of Neurochemistry
36. Critical Role of Truncated α‐Synuclein and Aggregates in Parkinson's Disease and Incidental Lewy Body Disease
    Kavita Prasad, Thomas G. Beach, John C. Hedreen, Eric K. Richfield · 2012 · Brain Pathology
37. Autonomic function, as self-reported on the SCOPA-autonomic questionnaire, is normal in essential tremor but not in Parkinson's disease
    Anne Damian, Charles H. Adler, Joseph G. Hentz, Holly A. Shill, John N. Caviness, Marwan Noel Sabbagh, Virgilio Gerald H. Evidente, Thomas G. Beach, Erika D. Driver‐Dunckley · 2012 · Parkinsonism & Related Disorders
38. Fixation, processing, and immunochemical reagent effects on preservation of T-lymphocyte surface membrane antigens in paraffin-embedded tissue.
    K Pollard, Declan Patrick Lunny, C S Holgate · 1987 · Journal of Histochemistry & Cytochemistry
39. Alzheimer disease periventricular white matter lesions exhibit specific proteomic profile alterations
    Eduardo M. Casta�o, Chera L. Maarouf, Terence Wu, María Celeste Leal, Charisse M. Whiteside, Lih‐Fen Lue, Tyler A. Kokjohn, Marwan Noel Sabbagh, Thomas G. Beach, Alex E. Roher · 2012 · Neurochemistry International
40. Chemical characterization of pro-inflammatory amyloid-beta peptides in human atherosclerotic lesions and platelets
    Tyler A. Kokjohn, Gregory D. Van Vickle, Chera L. Maarouf, Walter M. Kalback, Jesse M. Hunter, Ian D. Daugs, Dean C. Luehrs, John C. Lopez, Daniel C. Brune, Lucia I. Sue et al. · 2011 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
41. beta-amyloid load is not influenced by the severity of cardiovascular disease in aged and demented patients.
    Alafuzoff Irina, Helisalmi Seppo, Mannermaa Arto, Riekkinen Paavo, Soininen Hilkka · 1999 · Stroke
42. Do the Dead Have Interests? Policy Issues for Research After Life
    Dorothy Nelkin, Lori B. Andrews · 1998 · American Journal of Law & Medicine
43. Pathologic and Nicotinic Receptor Binding Differences Between Mild Cognitive Impairment, Alzheimer Disease, and Normal Aging
    Sabbagh, Marwan N., Shah, Flora, Reid, Richard T., Sue, Lucia, Connor, Donald J., Peterson, Lars Kristofer N., Beach, Thomas G. · 2006 · Archives of Neurology
44. Essential tremor and Parkinson's disease: Lack of a link
    Charles H. Adler, Holly A. Shill, Thomas G. Beach · 2011 · Movement Disorders
45. An optimistic view for quantifying mRNA in post-mortem human brain
    Paul Preece, David J. Virley, Moheb Costandi, Robert Coombes, Stephen J. Moss, Anne W. Mudge, ELENA E. JAZIN, Nigel J. Cairns · 2003 · Molecular Brain Research
46. Modeling Alzheimer's disease immune therapy mechanisms: Interactions of human postmortem microglia with antibody‐opsonized amyloid beta peptide
    Lih‐Fen Lue, Douglas G. Walker · 2002 · Journal of Neuroscience Research
47. Characterization of glial cultures from rapid autopsies of Alzheimer's and control patients
    Lih‐Fen Lue, Libuse Brachova, Douglas G. Walker, Joseph Rogers · 1996 · Neurobiology of Aging
48. Identification of Brain Cell Death Associated Proteins in Human Post-mortem Cerebrospinal Fluid
    Jennifer Burgess, Pierre Lescuyer, Alexandre Hainard, Pierre R. Burkhard, Natacha Turck, Philippe Michel, Joël S. Rossier, Frédéric Reymond, Denis F. Hochstrasser, Jean‐Charles Sanchez · 2006 · Journal of Proteome Research
49. Brain biochemistry in autopsied patients with essential tremor
    Holly A. Shill, Charles H. Adler, Thomas G. Beach, Lih‐Fen Lue, John N. Caviness, Marwan Noel Sabbagh, Lucia I. Sue, Douglas G. Walker · 2011 · Movement Disorders
50. Small‐Amplitude cortical myoclonus in Parkinson's disease: Physiology and clinical observations
    John N. Caviness, Charles H. Adler, Thomas G. Beach, Kristin L Wetjen, Richard J. Caselli · 2002 · Movement Disorders
51. Neuropathological findings of PSP in the elderly without clinical PSP: Possible incidental PSP?
    Virgilio Gerald H. Evidente, Charles H. Adler, Marwan Noel Sabbagh, Donald J. Connor, Joseph G. Hentz, John N. Caviness, Lucia I. Sue, Thomas G. Beach · 2011 · Parkinsonism & Related Disorders
52. Correlation of Clinical Features With Argyrophilic Grains at Autopsy
    Marwan Noel Sabbagh, Sonny S. Sandhu, Martin Rhys Farlow, Linda J. Vedders, Holly A. Shill, John N. Caviness, Donald J. Connor, Lucia I. Sue, Charles H. Adler, Thomas G. Beach · 2009 · Alzheimer Disease & Associated Disorders
53. Early Growth Response 3 (Egr3) Is Highly Over-Expressed in Non-Relapsing Prostate Cancer but Not in Relapsing Prostate Cancer
    Rebecca Pio, Zhenyu Jia, Veronique T. Baron · 2013 · PLoS ONE
54. Altered Hippocampal Kainate-Receptor mRNA Levels in Temporal Lobe Epilepsy Patients
    Gary W. Mathern, James K. Pretorius, Harley I. Kornblum, Delia Mendoza, Alana Lozada, João Pereira Leite, Leila M C Chimelli, Donald E. Born, Itzhak Fried, Américo Ceiki Sakamoto et al. · 1998 · Neurobiology of Disease
55. Initial Assessment of the Pathogenic Mechanisms of the Recently Identified Alzheimer Risk Loci
    Holton, Patrick, Ryten, Mina, Nalls, Michael, Trabzuni, Daniah, Weale, Michael E., Hernandez, Dena, Crehan, Helen, Gibbs, J. Raphael, Mayeux, Richard, Haines, Jonathan L. et al. · 2013 · Annals of Human Genetics
56. Neuronal gene expression correlates of Parkinson's disease with dementia
    Chelsea Stamper, Andrew M. Siegel, Winnie S. Liang, John V. Pearson, Dietrich A. Stephan, Holly A. Shill, Don Connor, John N. Caviness, Marwan Sabbagh, Thomas G. Beach et al. · 2008 · Movement Disorders
57. Quantitation of heteroplasmy of mtDNA sequence variants identified in a population of AD patients and controls by array-based resequencing
    Keith D. Coon, Jon Valla, Szabolics Szelinger, Lonnie E. Schneider, Tracy L. Niedzielko, Kevin M. Brown, John V. Pearson, Rebecca F. Halperin, Travis L. Dunckley, Andreas Papassotiropoulos et al. · 2006 · Mitochondrion
58. Heat‐Shock 70 Messenger RNA Levels in Human Brain: Correlation with Agonal Fever
    Marcelle Morrison‐Bogorad, Anton L. Zimmerman, Sibile Pardue · 1995 · Journal of Neurochemistry
59. Functional Ability Correlates with Cognitive Impairment in Parkinson’s Disease and Alzheimer’s Disease
    Marwan Noel Sabbagh, Tyson Lahti, Donald J. Connor et al. · 2007 · Dementia and Geriatric Cognitive Disorders
60. Genetic studies of neuropsychiatric disorders in Costa Rica: a model for the use of isolated populations
    Carol A. Mathews, Victor I. Reus, Julio Bejarano, Michael Escamilla, Eduardo Fournier, Luis Diego Herrera, Thomas L. Lowe, Lynne Alison McInnes, Julio Molina, Roel A. Ophoff et al. · 2004 · Psychiatric Genetics
61. Are there differences in cerebral white matter lesion burdens between Parkinson’s disease patients with or without dementia?
    Sun-Ah Choi, Virgilio Gerald H. Evidente, John N. Caviness · 2009 · Acta Neuropathologica
62. Genetics of frontotemporal lobar degeneration: An up-date and diagnosis algorithm
    Isabelle Le Ber · 2013 · Revue Neurologique
63. Association between the HLA-DR alleles and longevity: a study in Sardinian population
    Domenico Lio, Giovanni Mario Pes, Ciriaco Carru, Florinda Listı̀, Viviana Ferlazzo, Giuseppina Candore, Giuseppina Colonna‐Romano, Luigi Ferrucci, Luca Deiana, Giovannella Baggio et al. · 2003 · Experimental Gerontology
64. The biochemical aftermath of anti-amyloid immunotherapy
    Chera L. Maarouf, Ian D. Daugs, Tyler A. Kokjohn, Walter M. Kalback, Rebekah Patton, Dean C. Luehrs, Eliezer Masliah, James A. R. Nicoll, Marwan Noel Sabbagh, Thomas G. Beach et al. · 2010 · Molecular Neurodegeneration
65. Genetic counseling for FTD/ALS caused by the C9ORF72 hexanucleotide expansion
    Jamie C Fong, Anna M. Karydas, Jill S. Goldman · 2012 · Alzheimer s Research & Therapy
66. Proteomic Analysis of Cerebrospinal Fluid Changes Related to Postmortem Interval
    Erin J. Finehout, Zsofia Franck, Norman R. Relkin · 2006 · Clinical Chemistry
67. Antibody Responses, Amyloid-β Peptide Remnants and Clinical Effects of AN-1792 Immunization in Patients with AD in an Interrupted Trial
    Tyler A. Kokjohn, Alex E. Roher · 2009 · CNS & Neurological Disorders - Drug Targets
68. DNA Fingerprinting from Tissues After Variable Postmortem Periods
    Bertrand Ludes, Hélène Pfitzinger, P Mangin · 1993 · Journal of Forensic Sciences
69. Presence of Striatal Amyloid Plaques in Parkinson's Disease Dementia Predicts Concomitant Alzheimer's Disease: Usefulness for Amyloid Imaging
    Brittany N. Dugger, Geidy E. Serrano, Lucia I. Sue, Douglas G. Walker, Charles H. Adler, Holly A. Shill, Marwan Noel Sabbagh, John N. Caviness, Jose Hidalgo, Megan Saxon‐LaBelle et al. · 2012 · Journal of Parkinson s Disease
70. Critical Evaluation of Postmortem Changes in Human Autopsy Cisternal Fluid. Enzymes, Electrolytes, Acid-Base Balance, Glucose and Glycolysis, Free Amino Acids and Ammonia. Correlation to Total Brain Ischemia
    J. Kärkelä · 1993 · Journal of Forensic Sciences
71. Cardiovascular disease and risk of Alzheimer's disease
    Caterina Rosano, Anne B. Newman · 2006 · Neurological Research
72. Cardiac risk factors and potential treatments in Alzheimer's disease
    Christine Bergmann, Mary C. Sano · 2006 · Neurological Research
73. FOXO3 Encodes a Carcinogen-Activated Transcription Factor Frequently Deleted in Early-Stage Lung Adenocarcinoma
    Oliver R. Mikse, Daniel C. Blake, Nathan R. Jones, Yuan‐Wan Sun, Shantu Amin, Carla J. Gallagher, Philip J. Lazarus, Judith Weisz, Christopher R. Herzog · 2010 · Cancer Research
74. Expression Changes in the Stroma of Prostate Cancer Predict Subsequent Relapse
    Zhenyu Jia, Farah B. Rahmatpanah, Xin Chen, Waldemar Lernhardt, Yipeng Wang, Xiao-Qin Xia, Anne Sawyers, Manuel Sutton, Michael McClelland, Dan Mercola · 2012 · PLoS ONE
75. Motor impairment in normal aging, clinically possible Parkinson's disease, and clinically probable Parkinson's disease: longitudinal evaluation of a cohort of prospective brain donors
    Charles H. Adler, Joseph G. Hentz, Jeffrey N. Joyce · 2002 · Parkinsonism & Related Disorders
76. Human postmortem brain-derived cerebrovascular smooth muscle cells express all genes of the classical complement pathway: A potential mechanism for vascular damage in cerebral amyloid angiopathy and Alzheimer's disease
    Douglas G. Walker, Jessica E. Dalsing-Hernandez, Lih‐Fen Lue · 2007 · Microvascular Research
77. Evaluation of Parkinson Disease Risk Variants as Expression-QTLs
    Jeanne C. Latourelle, Alexandra Dumitriu, Tiffany C. Hadzi, Thomas G. Beach, Richard H. Myers · 2012 · PLoS ONE
78. Corticomuscular coherence is increased in the small postural tremor of Parkinson's disease
    John N. Caviness, Holly A. Shill, Marwan Noel Sabbagh, Virgilio Gerald H. Evidente, Jose Luis Hernández‐Davó, Charles H. Adler · 2005 · Movement Disorders
79. The healthy control subject in psychiatric research: impulsiveness and volunteer bias
    J. P. Gustavsson, M. Åsberg, O. Schilling · 1997 · Acta Psychiatrica Scandinavica
80. Patients With Alzheimer Disease Have Altered Transmitral Flow
    Marek Bëlohlávek, Panupong Jiamsripong, Anna M. Calleja, Eileen M. McMahon, Chera L. Maarouf, Tyler A. Kokjohn, Teresa L. Chaffin, Linda J. Vedders, Zsolt F. Garami, Thomas G. Beach et al. · 2009 · Journal of Ultrasound in Medicine
81. Neuropathologic Heterogeneity Does Not Impair Florbetapir-Positron Emission Tomography Postmortem Correlates
    Brittany N. Dugger, Christopher M. Clark, Geidy E. Serrano, Monica Mariner, Barry J. Bedell, Robert Edward Coleman, Pudugramam Murali Doraiswamy, Ming‐Chi Lu, Adam Fleisher, Eric M. Reiman et al. · 2013 · Journal of Neuropathology & Experimental Neurology
82. Theoretical Impact of Florbetapir (18F) Amyloid Imaging on the Diagnosis of Alzheimer’s Dementia and the Detection of Preclinical Cortical Amyloid
    T. Beach, J. Schneider, L. Sue, G. Serrano, B. Dugger, Sarah E. Monsell, W. Kukull · 2014 · Journal of Neuropathology and Experimental Neurology
83. Are post-mortem biochemical studies of human brain worthwhile?
    Alan M. Palmer, Stephen Loucian Lowe, Paul T. Francis, David M. Bowen · 1988 · Biochemical Society Transactions
84. Infiltration of T Lymphocytes and Expression of ICAM-1 in the Hippocampus of Patients with Hippocampal Sclerosis
    Hiroaki Nakahara, Yoshihiro Konishi, Thomas G. Beach, Naoto Yamada, Satoshi Makino, Ikuo Tooyama · 2010 · ACTA HISTOCHEMICA ET CYTOCHEMICA
85. Interventions for heart disease and their effects on Alzheimer's disease
    Benjamin L. Wolozin, Martin M. Bednar · 2006 · Neurological Research
86. Dynamic Changes of the Phosphoproteome in Postmortem Mouse Brains
    Tsutomu Oka, Kazuhiko Tagawa, Hikaru Ito, Hitoshi Okazawa · 2011 · PLoS ONE
87. Pathology in essential tremor
    Holly A. Shill, Charles H. Adler, Thomas G. Beach · 2011 · Parkinsonism & Related Disorders
88. Autonomic complaints in patients with restless legs syndrome
    Natalya Shneyder, Charles H. Adler, Joseph G. Hentz, Holly A. Shill, John N. Caviness, Marwan Noel Sabbagh, Thomas G. Beach, Erika D. Driver‐Dunckley · 2013 · Sleep Medicine
89. Bapineuzumab Alters Aβ Composition: Implications for the Amyloid Cascade Hypothesis and Anti-Amyloid Immunotherapy
    Alex E. Roher, David H. Cribbs, Ronald C. Kim, Chera L. Maarouf, Charisse M. Whiteside, Tyler A. Kokjohn, Ian D. Daugs, Elizabeth Head, Carolyn Liebsack, Geidy E. Serrano et al. · 2013 · PLoS ONE
90. Proteomic Analysis of Alzheimers Disease Cerebrospinal Fluid from Neuropathologically Diagnosed Subjects
    Chera L. Maarouf, Tracy M. Andacht, Tyler A. Kokjohn, Eduardo Miguel Castaño, Lucia I. Sue, Thomas G. Beach, Alex E. Roher · 2009 · Current Alzheimer Research
91. Abnormal corticomuscular coherence is associated with the small amplitude cortical myoclonus in Parkinson's disease
    John N. Caviness, Charles H. Adler, Marwan Noel Sabbagh, Donald J. Connor, Jose Luis Hernández‐Davó, Terrence D. Lagerlund · 2003 · Movement Disorders
92. Motor unit number estimates in idiopathic Parkinson's disease
    John N. Caviness, Benn E. Smith, J. Clarke Stevens, Charles H. Adler, Richard J. Caselli, Joseph G. Hentz, M.S. Manfred, D. Muenter · 2002 · Parkinsonism & Related Disorders
93. Apolipoprotein E phenotypes in demented and cognitively impaired patients with and without cerebrovascular disease
    Latchezar Dintchov Traykov, Anne‐Sophie Rigaud, Ludovica Caputo, Rémy Couderc, Joël Coste, Jean–Luc Michot, Jocelyne de Rotrou, Philippe Amouyel, Françoise Forette, François Boller · 1999 · European Journal of Neurology
94. Cytoskeletal Messenger RNA Stability in Human Neocortex: Studies in Normal Aging and in Alzheimer's Disease
    Walter J. Lukiw, Lee Jun Wong, Donald R. Crapper McLachlan · 1990 · International Journal of Neuroscience
95. Occurrence of diffuse amyloid deposits in the presubicular parvopyramidal layer in Alzheimer's disease
    Haruhiko Akiyama, Hisao Tago, Shigeru Itagaki, Patrick L. McGeer · 1990 · Acta Neuropathologica
96. Postmortem stability of dopamine D1 receptor mRNA and D1 receptors
    John H. Gilmore, Cindy P. Lawler, Allison M. Eaton, Richard B. Mailman · 1993 · Molecular Brain Research
97. Selective postmortem degradation of inducible heat shock protein 70 (hsp70) mRNAs in rat Brain
    Sibile Pardue, Anton L. Zimmerman, Marcelle Morrison‐Bogorad · 1994 · Cellular and Molecular Neurobiology
98. The Human Amyloid-β Precursor Protein770 Mutation V717F Generates Peptides Longer Than Amyloid-β-(40-42) and Flocculent Amyloid Aggregates
    Alex E. Roher, Tyler A. Kokjohn, Chera L. Esh, Nicole Weiss, Jennifer Childress, Walter M. Kalback, Dean C. Luehrs, John C. Lopez, Daniel C. Brune, Yu‐Min Kuo et al. · 2004 · Journal of Biological Chemistry
99. Comparison of silver stainings and immunohistology for the detection of neurofibrillary tangles and extracellular cerebral amyloid in paraffin sections
    A. Rosenwld, Erich Reusche, Koji Ogomori · 1993 · Acta Neuropathologica
100. Alzheimer's Disease and the “Valley of Death”: Not Enough Guidance from Human Brain Tissue?
     Thomas G. Beach · 2012 · Journal of Alzheimer s Disease
101. Proteomic investigations of the ventriculo-lumbar gradient in human CSF
     Anja Hviid Simonsen, Sára Bech, Inga Laursen, Lisette Salvesen, Kristian Winge, Gunhild Waldemar, Lene Werdelin, Jørgen Erik Nielsen, James N. McGuire, Lena E. Hjermind · 2010 · Journal of Neuroscience Methods
102. Motor learning in essential tremor
     Holly A. Shill, Frederick J. De La Vega, Johan Samanta · 2009 · Movement Disorders
103. Electrophysiology of the myoclonus in dementia with Lewy bodies
     John N. Caviness, Charles H. Adler, Richard J. Caselli · 2003 · Neurology
104. Atherosclerosis and AD: Analysis of data from the US National Alzheimer's Coordinating Center
     Alex E. Roher, Chera L. Esh, Tyler A. Kokjohn, Lucia I. Sue, Thomas G. Beach · 2005 · Neurology
105. Neuropathology and Amyloid-β Spectrum in a Bapineuzumab Immunotherapy Recipient
     Alex E. Roher, Chera L. Maarouf, Ian D. Daugs, Tyler A. Kokjohn, Jesse M. Hunter, Marwan Noel Sabbagh, Thomas G. Beach · 2011 · Journal of Alzheimer s Disease
106. Alzheimer's lesions labelled by anti‐ubiquitin antibodies: comparison with other staining techniques. A study of 15 cases with graded intellectual status in ageing and Alzheimer's disease
     Y. He, Charles J. Duyckaerts, Pia Delaère, F. Piette, J J Hauw · 1993 · Neuropathology and Applied Neurobiology
107. Parkinson's disease, cortical dysfunction, and alpha‐synuclein
     John N. Caviness, Lih‐Fen Lue, Thomas G. Beach, Joseph G. Hentz, Charles H. Adler, Lucia I. Sue, Ramin Sadeghi, Erika D. Driver‐Dunckley, Virgilio Gerald H. Evidente, Marwan Noel Sabbagh et al. · 2011 · Movement Disorders
108. In vitro-differentiated neural cell cultures progress towards donor-identical brain tissue.
     B. Hjelm, B. Salhia, Ahmet A. Kurdoglu, S. Szelinger, R. Reiman, L. Sue, T. Beach, M. Huentelman, David W. Craig · 2013 · Human Molecular Genetics
109. Induction of pluripotent stem cells from autopsy donor-derived somatic cells
     Brooke E. Hjelm, Jon B. Rosenberg, Szabolcs Szelinger, Lucia I. Sue, Thomas G. Beach, Matthew J. Huentelman, David Wesley Craig · 2011 · Neuroscience Letters
110. Presenilin-1 280Glu→Ala Mutation Alters C-Terminal APP Processing Yielding Longer Aβ Peptides: Implications for Alzheimer’s Disease
     Gregory D. Van Vickle, Chera L. Esh, Tyler A. Kokjohn, Rebekah Patton, Walter M. Kalback, Dean C. Luehrs, Thomas G. Beach, Amanda Newell, Francisco Javier Lopera, Bernardino Francesco Ghetti et al. · 2008 · Molecular Medicine
111. Relative protection from cerebral atherosclerosis of young patients with homozygous familial hypercholesterolemia
     Alfredo Postiglione, Antonio Nappi, Arturo Brunetti et al. · 1991 · Atherosclerosis
112. Correlation of the Expression Level of C1q mRNA and the Number of C1q-Positive Plaques in the Alzheimer Disease Temporal Cortex
     Ikuo Tooyama, Haruhisa Sato, Osamu Yasuhara, Hiroshi Kimura, Yoshinori Konishi, Yong Shen, Douglas G. Walker, Thomas G. Beach, Lucia I. Sue, Joseph Rogers · 2001 · Dementia and Geriatric Cognitive Disorders
113. The postmortem Alzheimer brain is a source of structurally and functionally intact astrocytic messenger RNA
     Elizabeth M. Sajdel, Ronald E. Majocha, M. Salim, Sayeeda B. Zain, Charles A. Marotta · 1988 · Journal of Neuroscience Methods
114. A Comparison of Genome-scans Performed in Multicase Families with Systemic Lupus Erythematosus from Different Population Groups
     Bo Johanneson, Kristján Steinsson, Anna-Karin Lindqvist et al. · 1999 · Journal of Autoimmunity
115. Positive Florbetapir PET Amyloid Imaging in a Subject with Frequent Cortical Neuritic Plaques and Frontotemporal Lobar Degeneration with TDP43-Positive Inclusions
     Geidy E. Serrano, Marwan Noel Sabbagh, Lucia I. Sue, Jose A. Hidalgo, Julie A. Schneider, Barry J. Bedell, Vivianna M. Van Deerlin, EunRan R. Suh, Haruhiko Akiyama, Abhinay D. Joshi et al. · 2014 · Journal of Alzheimer s Disease
116. Is the functional decline of Parkinson's disease similar to the functional decline of Alzheimer's disease?
     Marwan Noel Sabbagh, Nina B. Silverberg, S. Bircea · 2005 · Parkinsonism & Related Disorders
117. Reduced clinical and postmortem measures of cardiac pathology in subjects with advanced Alzheimer's Disease
     Thomas G. Beach, Chera L. Maarouf, Reed G Brooks, Scophil Shirohi, Ian D. Daugs, Lucia I. Sue, Marwan Noel Sabbagh, Douglas G Walker, Lih‐Fen Lue, Alex E. Roher · 2011 · BMC Geriatrics
118. Purkinje cell loss in essential tremor
     Elan D. Louis, Phyllis L. Faust · 2014 · Movement Disorders
119. Secular trends in atherosclerosis of coronary arteries and basal cerebral arteries in Japan. The Akita pathology study.
     Masamitsu Konishi, Yoshio Komachi, Hiroyasu Iso, M Iida, Y Naito, Shunsuke Sato, Masahiko Kiyama, Takashi Shimamoto, Akihiko Kitamura, Mitsunori Doi · 1990 · Arteriosclerosis An Official Journal of the American Heart Association Inc
120. Stakeholder Research on Biospecimen Needs and Reactions to the Development of a National Cancer Human Biobank by the National Cancer Institute
     R. Myles, Holly A. Massett, G. Comey, N. Atkinson, D. Allsop, Carolyn C. Compton · 2011 · JNCI Monographs
121. Elucidating Molecular Mechanisms of Alzheimer’s Disease in Microglial Cultures
     J. Rogers, Lih‐Fen Lue, Douglas G. Walker, S D Yan, D Stern, Ron Strohmeyer, Carl J. Kovelowski · 2002 · Springer eBooks
122. SMG1 Identified as a Regulator of Parkinson’s Disease-Associated alpha-Synuclein through siRNA Screening
     Adrienne Henderson-Smith, Donald C. Chow, Bessie Meechoovet, Meraj Aziz, Sandra A. Jacobson, Holly A. Shill, Marwan Noel Sabbagh, John N. Caviness, Charles H. Adler, Erika D. Driver‐Dunckley et al. · 2013 · PLoS ONE
123. Myoclonus in Lewy body disorders.
     John N. Caviness, Charles H. Adler, Thomas G. Beach · 2002 · PubMed
124. Subjects harboring presenilin familial Alzheimer's disease mutations exhibit diverse white matter biochemistry alterations.
     Alex E. Roher, Chera L. Maarouf, Michael H. Malek‐Ahmadi, Jeffrey Wilson, Tyler A. Kokjohn, Ian D. Daugs, Charisse M. Whiteside, Walter M. Kalback, Mi Mi P. Macias, Sandra A. Jacobson et al. · 2013 · Europe PMC (PubMed Central)
125. Expressional potency of mRNAs encoding receptors and voltage-activated channels in the postmortem rat brain.
     David S. Ragsdale, Ricardo Miledi · 1991 · Proceedings of the National Academy of Sciences
126. Ventral striatal D3 receptors and Parkinson's Disease
     Jeffrey N. Joyce, H. Ryoo, Eugenia V. Gurevich, Charles H. Adler, Thomas G. Beach · 2001 · Parkinsonism & Related Disorders
127. Plaques and Tangles: Searching for Primary Events in a Forest of Data
     Brian J Cummings · 1997 · Neurobiology of Aging
128. Coronary and cerebrovascular atherosclerosis: two aspects of the same disease or two different pathologies?
     Paolo Puddu, Giovanni M. Puddu, Luciana Bastagli, Giorgio Massarelli, Antonio Muscari · 1995 · Archives of Gerontology and Geriatrics
129. The temporal localization of frame-shift ubiquitin-B and amyloid precursor protein, and complement proteins in the brain of non-demented control patients with increasing Alzheimer's disease pathology
     Yoshihiro Konishi, Thomas G. Beach, Lucia I. Sue, Harald Juergen Hampel, Kristina Lindholm, Yong Shen · 2003 · Neuroscience Letters
130. Quantitative Appraisal of Ventricular Cerebrospinal Fluid Biomarkers in Neuropathologically Diagnosed Parkinson's Disease Cases Lacking Alzheimer's Disease Pathology
     Chera L. Maarouf, Thomas G. Beach, Charles H. Adler, Michael H. Malek‐Ahmadi, Tyler A. Kokjohn, Brittany N. Dugger, Douglas G. Walker, Holly A. Shill, Sandra A. Jacobson, Marwan Noel Sabbagh et al. · 2013 · Biomarker Insights
131. Adipose and leptomeningeal arteriole endothelial dysfunction induced by β-amyloid peptide: A practical human model to study Alzheimer's disease vasculopathy
     Seth Truran, Daniel A. Franco, Alex E. Roher, Thomas G. Beach, Camelia Burciu, Geidy E. Serrano, Chera L. Maarouf, Sara Schwab, Jenna Anderson, Joseph Georges et al. · 2014 · Journal of Neuroscience Methods
132. Genetics in Degenerative Dementia
     Amalia Cecilia Bruni, Maria Elena Conidi, Livia Bernardi · 2014 · Alzheimer Disease & Associated Disorders
133. Characteristics of research volunteers for inpatient cocaine studies: focus on selection bias.
     Mehmet Sofuoglu, Susan Dudish-Poulsen, Kristin K. Nicodemus, David A. Babb, Dorothy K. Hatsukami · 2000 · Addictive Behaviours
134. Measurement of Altered AβPP Isoform Expression in Frontal Cortex of Patients with Alzheimer's Disease by Absolute Quantification Real-Time PCR
     William G. Tharp, Yong‐ho Lee, Shane M. Greene, Elise Vincellete, Thomas G. Beach, Richard E. Pratley · 2012 · Journal of Alzheimer s Disease
135. Postmortem Interval Influencesα-Synuclein Expression in Parkinson Disease Brain
     Alexandra Dumitriu, Carlee Moser, Tiffany C. Hadzi · 2012 · Parkinson s Disease
136. Incidental Lewy body disease: Electrophysiological findings suggesting pre-clinical Lewy body disorders
     John N. Caviness, Charles H. Adler, Joseph G. Hentz, Holly A. Shill, Virgilio Gerald H. Evidente, Erika D. Driver‐Dunckley, Marwan Noel Sabbagh, Lucia I. Sue, Thomas G. Beach · 2011 · Clinical Neurophysiology
137. BACE1 Levels by APOE Genotype in Non-Demented and Alzheimer’s Post-Mortem Brains
     Boris Decourt, Amanda Gonzales, T. Beach, Michael Malek-Ahmadi, Aaron Walker, L. Sue, D. Walker, M. Sabbagh · 2013 · Current Alzheimer Research
138. Genomic analysis and selected molecular pathways in rare cancers
     Stephen V. Liu, Elizabeth Lenkiewicz, Lisa Evers, Tara Holley, Jeffrey Kiefer, Christian Felipe Ruiz, Katharina Glatz, Lukas Bubendorf, Michael J. Demeure, Cathy Eng et al. · 2012 · Physical Biology
139. An Examination of Bias in Volunteer Subject Selection: Findings from an In-Depth Child Abuse Study
     Francine S. Mandel, Merrill Weiner, S. Kaplan, D. Pelcovitz, V. Labruna · 2000 · Journal of Traumatic Stress
140. The 2006 Revised Uniform Anatomical Gift Act—A Law to Save Lives
     Herbert Hovenkamp, Mark Weston Janis, Mark A. Lemley · 2007 · Iowa Research Online (The University of Iowa)
141. Analysis of staining methods for different cortical plaques in Alzheimer's disease
     G. Halliday, Dimity Flowers, L. Baum · 1994 · Acta Neuropathologica
142. Functional and genetic analysis of haplotypic sequence variation at the nicastrin genomic locus
     Gillian Hamilton, Richard Killick, Jean‐Charles Lambert, Philippe Amouyel, Minerva M. Carrasquillo, V. Shane Pankratz, Neill R. Graff‐Radford, Dennis W. Dickson, Ronald Carl Petersen, Steven G. Younkin et al. · 2012 · Neurobiology of Aging
143. Reply: Purkinje cell loss in essential tremor
     Holly A. Shill, Charles H. Adler, Joseph G. Hentz · 2014 · Movement Disorders
144. Cholesterol, atherosclerosis and cerebro-cardiovascular complications in 3,236 elderly autopsy cases.
     Kizuku Kuramoto, Seigo Ueda, Satoru Matsushita · 1991 · Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics
145. Mild cognitive impairment in Parkinson's disease
     Charles H. Adler · 2009 · Parkinsonism & Related Disorders
146. Clonal Evolution of a Case of Treatment Refractory Maxillary Sinus Carcinoma
     Shilpi Arora, Ronald Lee Korn, Elizabeth Lenkiewicz · 2012 · PLoS ONE
147. Untitled work
     Webster · 1996 · 10.1002/(sici)1097-4547(19961001)46:1